In relation to the poor outcomes of immunotherapy and drug therapy in glioma patients, we found that glioma CASP4 expression correlated with the degree of infiltration of multiple immune cell types and sensitivity to chemotherapeutic agents. This evidence concerns the gene CASP4 and glioma.